PHLDB3 and malignant colon neoplasm: Using colon cancer cell lines for colongenic assays, we found that knockdown of PHLDB3 lead to statistically significant reduction of colony formation in both p53-containing and p53-deficient HCT116 cells, but clearly more dramatically in p53-positive colon cancer cells (Fig. 4j,k).